NSE: ANURAS | BSE: 543275

Momentum Trap

Download real time

770.65 -4.15 (-0.54%)

28.23% Gain from 52W Low

254.1K NSE+BSE Volume

NSE 21 Mar, 2025 3:31 PM (IST)

8,471.9

Market Cap

High in industry

0.5

Beta 1Year

Very Low volatility

Anupam Rasayan India Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for ANURAS, BSE:543275 Anupam Rasayan India Ltd.

Search Inside the pdf :

Anupam Rasayan India Ltd.

20 Nov 2024

770.65

-0.54%

Persistent pressure in Agrochemcial segment to continue

Hold: Anupam Rasayan India Ltd.

Target

KRChoksey

Anupam Rasayan’s revenue missed our estimates significantly due to weak demand in Agrochemical segment. EBITDA and Adj. PAT missed our estimates significantly due to operating deleverage and lower than expected other income.

Anupam Rasayan India Ltd. is trading above all available SMAs

Anupam Rasayan India Ltd.

27 Aug 2024

770.65

-0.54%

Pharma and polymer segment will drive growth from H2FY25E

Accumulate: Anupam Rasayan India Ltd.

Target

KRChoksey

Anupam Rasayan’s revenue missed our estimate due to weak demand in Agrochemical segment. EBITDA missed our estimate due to higher operating expenses.

Promoters pledged 2.72% of shares in last quarter. Total pledge stands at 16.47% of promoter holdings

Anupam Rasayan India Ltd.

27 May 2024

770.65

-0.54%

Pharma and polymer segment will drive growth

Accumulate: Anupam Rasayan India Ltd.

Target

KRChoksey

Anupam Rasayan’s revenue beat our estimate but EBITDA missed our estimate due to higher-than-expected cost of goods sold which was partially offset by lower-than-expected employee expenses and lower than expected other expenses.
Currently, the stock is trading at 43.7x/27.8x, based on FY25E/FY26E EPS respectively.

Promoters pledged 2.72% of shares in last quarter. Total pledge stands at 16.47% of promoter holdings

Anupam Rasayan India Ltd.

20 Feb 2024

770.65

-0.54%

Strategy to diversify into pharma, polymer, and Japanese market drive growth

Accumulate: Anupam Rasayan India Ltd.

Target

KRChoksey

For Q3FY24, Anupam Rasayan’s revenue declined 24.6% YoY (-24.6% QoQ) to INR 2,955 Mn. For 9MFY24, the revenue declined by 4.3% YoY to INR 10,741 Mn.

Anupam Rasayan India Ltd. is trading above all available SMAs

Anupam Rasayan India Ltd.

22 Nov 2023, 12:00AM

770.65

-0.54%

Weak quarterly performance due to lack of demand in end customer business

Accumulate: Anupam Rasayan India Ltd.

Recommendation Target

KRChoksey

For Q2FY24, ANURAS revenue declined marginally by 0.2% YoY but increased by 1.5% QoQ to INR 3,921 Mn while for H1FY24, the revenue increased by 5.7% YoY to INR 7,785 Mn. This muted quarterly performance was due to a lack of demand from major clients in the export market and it is expected there will be an increased demand for the upcoming two quarters (H2FY24E), resulting in sales figures for the second half of the year being expected to align closely with those of the previous year.

Promoters pledged 2.72% of shares in last quarter. Total pledge stands at 16.47% of promoter holdings

Anupam Rasayan India Ltd.

04 Oct 2023

770.65

-0.54%

ANUPAM RASAYAN INDIA

Not Rated: Anupam Rasayan India Ltd.

Prabhudas Lilladhar

Promoters pledged 2.72% of shares in last quarter. Total pledge stands at 16.47% of promoter holdings

Anupam Rasayan India Ltd.

05 May 2023

770.65

-0.54%

Strong products launch pipeline providing revenue visibility

Buy: Anupam Rasayan India Ltd.

Target

KRChoksey

The company has delivered a strong revenue growth of 51.3% YoY and 25.4% QoQ due to the launch of 5 new products during the quarter and robust performance from Tanfac. Besides this, the company has entered into 3 new LOIs worth of INR 28,630 Mn with a contract period of 5-7 years.

Promoters pledged 2.72% of shares in last quarter. Total pledge stands at 16.47% of promoter holdings

Anupam Rasayan India Ltd.

03 Feb 2023

770.65

-0.54%

Strong products launch pipeline providing revenue visibility

Buy: Anupam Rasayan India Ltd.

KRChoksey

On a consolidated basis, Anupam Rasayan India Ltd (ARIL) reported revenue of INR 3.827Mn in Q3FY23 grew by +43.8% YoY and - 0.9% QoQ. YoY growth is not comparable as the effect of Tanfac’s acquisition given during the quarter. Revenue contribution from Life science - speciality chemicals and Other speciality chemicals was 82% and 18% respectively compared to 90% and 10% in Q2FY23.

Anupam Rasayan India Ltd. has gained 19.95% in the last 1 Month

Anupam Rasayan India Ltd.

12 Mar 2021

770.65

-0.54%

IPO Note - Exciting Chemistry - Subscribe

IPO Note: Anupam Rasayan India Ltd.

Prabhudas Lilladhar

Manufacturing (CSM) company, operates in Life sciences (95% of rev) and other specialty chemicals (5%) verticals. It is favorably placed in the sweet spot to capture the rising demand for specialty chemicals given its strong relationships with MNCs (Key clients- Syngenta, Sumitomo and UPL), leadership competencies into multi-step synthesis & complex chemistries such as etherification, hydrogenation, alkylation, nitration, etc and superior...

Anupam Rasayan India Ltd. has gained 19.95% in the last 1 Month

Anupam Rasayan India Ltd.

12 Mar 2021

770.65

-0.54%

Anupam Rasayan

IPO Subscribe: Anupam Rasayan India Ltd.

Angel Broking

Anupam Rasayan India Ltd. is a company engaged in the custom synthesis and manufacturing of specialty chemicals in India. Company started its business as a partnership firm in 1984 as a manufacturer of conventional products and have, over the years, evolved into custom synthesis and manufacturing of life science related specialty chemicals and other specialty

Anupam Rasayan India Ltd. has gained 19.95% in the last 1 Month

No results found

VOTE: Is Anupam Rasayan India Ltd. worth buying?

67 Votes:

Buy 80.6%

Sell 16.42%

Hold 2.99%

RESEARCH REPORTS

Hold SEE REPORTS >

pdf

Accumulate SEE REPORTS >

pdf